2-[(3S,6S,9R,12R,16E,21R)-12-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-guanidino-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoyl]amino]-6-tert-butyl-21-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-carbamoyl-4-guanidino-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]amino]-1-(1H-imidazol-5-ylmethyl)-2-oxo-ethyl]carbamoyl]-12,21-dimethyl-9-[(1S)-1-methylpropyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclohenicos-16-en-3-yl]acetic acid

ID: ALA5276549

Chembl Id: CHEMBL5276549

Max Phase: Preclinical

Molecular Formula: C111H178N40O20

Molecular Weight: 2392.90

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H]1NC(=O)[C@](C)(NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(C)=O)CCC/C=C/CCC[C@](C)(C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)C(C)C)C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)(C)C)NC1=O

Standard InChI:  InChI=1S/C111H178N40O20/c1-13-61(6)84-98(167)148-85(109(8,9)10)99(168)142-78(54-81(153)154)94(163)150-110(11,42-22-16-14-15-17-23-43-111(12,102(171)147-84)149-93(162)75(40-29-49-131-108(123)124)139-95(164)80-41-30-50-151(80)100(169)79(52-64-56-133-69-34-21-19-32-67(64)69)143-89(158)72(37-26-46-128-105(117)118)137-87(156)71(135-62(7)152)36-25-45-127-104(115)116)101(170)144-77(53-65-57-125-58-134-65)92(161)146-82(59(2)3)96(165)140-73(38-27-47-129-106(119)120)88(157)138-74(39-28-48-130-107(121)122)90(159)145-83(60(4)5)97(166)141-76(51-63-55-132-68-33-20-18-31-66(63)68)91(160)136-70(86(112)155)35-24-44-126-103(113)114/h14-15,18-21,31-34,55-61,70-80,82-85,132-133H,13,16-17,22-30,35-54H2,1-12H3,(H2,112,155)(H,125,134)(H,135,152)(H,136,160)(H,137,156)(H,138,157)(H,139,164)(H,140,165)(H,141,166)(H,142,168)(H,143,158)(H,144,170)(H,145,159)(H,146,161)(H,147,171)(H,148,167)(H,149,162)(H,150,163)(H,153,154)(H4,113,114,126)(H4,115,116,127)(H4,117,118,128)(H4,119,120,129)(H4,121,122,130)(H4,123,124,131)/b15-14+/t61-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,82-,83-,84+,85+,110+,111+/m0/s1

Standard InChI Key:  FBPLJGUEIUVSOO-OLKTYZICSA-N

Alternative Forms

1. Parent:

   

   ALA5276549

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 2392.90

Molecular Weight (Monoisotopic): 2391.4141

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Liu Z, Wang P, Wold EA, Song Q, Zhao C, Wang C, Zhou J..  (2021)  Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer.,  64  (8.0): [PMID:33822624] [10.1021/acs.jmedchem.0c01799]

Source

Source(1):

• Scientific Literature